Citation Impact
Citing Papers
Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL)
2005
Lymphoma Recurrence 5 Years or Later Following Diffuse Large B-Cell Lymphoma: Clinical Characteristics and Outcome
2010
miR-15 and miR-16 induce apoptosis by targeting BCL2
2005 Standout
Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte
2010 Standout
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 Standout
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Functional and morphological cardiac changes in myeloproliferative disorders (clinical study)
2004
Phosphorylation of ETS1 by Src Family Kinases Prevents Its Recognition by the COP1 Tumor Suppressor
2014 StandoutNobel
Role of genetic and epigenetic changes in Burkitt lymphoma
2002
JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis
2012 Standout
Signal integration by JNK and p38 MAPK pathways in cancer development
2009 Standout
Evidence that Prefibrotic Myelofibrosis Is Aligned along a Clinical and Biological Continuum Featuring Primary Myelofibrosis
2012
Head and neck cancer
2008 Standout
Hyperbaric Oxygen Ameliorates Bacterial Translocation in Rats with Mechanical Intestinal Obstruction
2002
Estimating the optimal utilization rates of radiotherapy for hematologic malignancies from a review of the evidence
2004
Multiple Myeloma
2004
WHO-EORTC classification for cutaneous lymphomas
2005 Standout
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
2013 Standout
Hypermethylation of tumor suppressor genes in cancer
1999
Functional antagonism of the Polycomb-Group genes eed and Bmi1 in hemopoietic cell proliferation
1999
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Indications for allogeneic stem cell transplantation in chronic lymphocytic leukemia: the EBMT transplant consensus
2006
Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity
2006 Standout
Blinded by the Light: The Growing Complexity of p53
2009 Standout
Richter syndrome
2004
Haemostatic abnormalities in patients with liver disease
2002
p16(MTS-1/CDKN2/INK4a) in Cancer Progression
2001
International Working Group (IWG) consensus criteria for treatment response in myelofibrosis with myeloid metaplasia, for the IWG for Myelofibrosis Research and Treatment (IWG-MRT)
2006
Gene Silencing in Cancer in Association with Promoter Hypermethylation
2003 Standout
Bone Marrow Histopathology in Myeloproliferative Disorders—Current Diagnostic Approach
2005
Hematopoietic Stem-Cell Transplantation
2006 Standout
Epstein–Barr virus: 40 years on
2004 Standout
Cancer treatment and survivorship statistics, 2012
2012 Standout
Programmed Cell Senescence during Mammalian Embryonic Development
2013 Standout
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
2014 Standout
Essential thrombocythemia, polycythemia vera, and myelofibrosis: Current management and the prospect of targeted therapy
2008
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Reflecting on 25 years with MYC
2008 Standout
Tumour-associated macrophages as treatment targets in oncology
2017 Standout
microRNAs as oncogenes and tumor suppressors
2006 Standout
Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia ("accelerated" chronic lymphocytic leukemia) with aggressive clinical behavior
2010
MicroRNA signatures in human cancers
2006 Standout
Genetic and epigenetic alterations of the INK4a–ARF pathway in cholangiocarcinoma
2002
Stem Cells and Cancer
2004 Standout
Defining the Role of mTOR in Cancer
2007 Standout
The chronic myeloproliferative disorders: Clonality and clinical heterogeneity
2004
Correlation Between Intraluminal Oxygen Gradient and Radial Partitioning of Intestinal Microbiota
2014 Standout
Protein therapeutics: a summary and pharmacological classification
2007 Standout
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
2005 StandoutNature
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
2005 Standout
Richter's transformation of chronic lymphocytic leukemia
2005
The history and future of targeting cyclin-dependent kinases in cancer therapy
2015 Standout
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
Flavopiridol, Fludarabine, and Rituximab in Mantle Cell Lymphoma and Indolent B-Cell Lymphoproliferative Disorders
2009
Transformation of follicular lymphoma to diffuse large-cell lymphoma: Alternative patterns with increased or decreased expression of c - myc and its regulated genes
2002
High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma
2006
T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
2011 Standout
BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas.
2001
Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma
2006
Inactivation of Tumor Suppressor Genes p15INK4b and p16INK4a in Primary Cutaneous B Cell Lymphoma
2002
Eradication of Minimal Residual Disease in B-Cell Chronic Lymphocytic Leukemia After Alemtuzumab Therapy Is Associated With Prolonged Survival
2005
The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP
2006 Standout
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid Malignancies
2017 StandoutNobel
Computed Tomography Scans Do Not Improve the Predictive Power of 1996 National Cancer Institute–Sponsored Working Group Chronic Lymphocytic Leukemia Response Criteria
2007
Ceramide glycosylation potentiates cellular multidrug resistance
2001
Distinct Role of Macrophages in Different Tumor Microenvironments
2006 Standout
ICOS+Foxp3+TILs in gastric cancer are prognostic markers and effector regulatory T cells associated withHelicobacter pylori
2016 StandoutNobel
Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic Leukemia
2005
Mechanisms of Cancer Drug Resistance
2002 Standout
Follicular Lymphoma in the United States: First Report of the National LymphoCare Study
2009
The role of radiotherapy in cancer treatment
2005 Standout
Improved survival in multiple myeloma and the impact of novel therapies
2007 Standout
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Chronic Thromboembolic Pulmonary Hypertension
2006 Standout
Cell cycle deregulation in B-cell lymphomas
2003
Risk-assessment in diffuse large cell lymphoma at first relapse. A study by the Italian Intergroup for Lymphomas.
2001
mice: Multivariate Imputation by Chained Equations inR
2011 Standout
Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy
2003
Impact of Natural Products on Developing New Anti-Cancer Agents
2009 Standout
Molecular Pathogenesis of Diffuse Large B-Cell Lymphoma
2005
Correlation between FDG/PET, histology, characteristics, and survival in 332 patients with chronic lymphoid leukemia
2014
Regulatory roles of IL-10–producing human follicular T cells
2019 StandoutNobel
JAK2 V617F mutational status predicts progression to large splenomegaly and leukemic transformation in primary myelofibrosis
2007
New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment
2008
Multiple Myeloma
2011 Standout
Rituximab for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin's lymphoma
2009
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
The Arf/p53 Pathway in Cancer and Aging
2008
Cancer treatment and survivorship statistics, 2014
2014 Standout
Works of Francesc Cobo being referenced
Risk of relapse and clinico‐pathological features in 103 patients with diffuse large‐cell lymphoma in complete response after first‐line treatment
1998
Fludarabine, cyclophosphamide and mitoxantrone in the treatment of resistant or relapsed chronic lymphocytic leukaemia
2002
Multiple cell cycle regulator alterations in Richter's transformation of chronic lymphocytic leukemia
2002
Limitations of Gallium‐67 SPECT in histological transformation of chronic lymphocytic leukaemia: an analysis of 13 patients with clinically suspected Richter's syndrome
2002
Identification of ‘short‐lived’ and ‘long‐lived’ patients at presentation of idiopathic myelofibrosis
1997
Survival after progression in patients with follicular lymphoma: analysis of prognostic factors
2002
Thalidomide in multiple myeloma: lack of response of soft‐tissue plasmacytomas
2001
INK4a/ARFLocus Alterations in Human Non-Hodgkin's Lymphomas Mainly Occur in Tumors with Wild-Type p53 Gene
2000
The changing profile of idiopathic myelofibrosis: a comparison of the presenting features of patients diagnosed in two different decades
1998
Non-Hodgkin's Lymphoma Associated with Gaucher's Disease
1998
[Idiopathic myelofibrosis: initial features, evolutive patterns and survival in a series of 106 patients].
1997
Abdominal Computed Tomography Predicts Progression in Patients With Rai Stage 0 Chronic Lymphocytic Leukemia
2007
p16INK4a Gene Inactivation by Deletions, Mutations, and Hypermethylation Is Associated With Transformed and Aggressive Variants of Non-Hodgkin's Lymphomas
1998
Morphology and Function of the Dog Ileum after Mechanical Occlusion
1976
Existence of A Platelet–Adhesion Defect in Patients With Cirrhosis Independent of Hematocrit: Studies Under Flow Conditions
1996